Document is current
Any future updates will be listed below
-
Authors
Watanabe-Fujinuma, Emi
Origasa, Hideki
Bamber, Luke
Roessig, Lothar
Toyoda, Tetsumi
Haga, Yuri https://orcid.org/0000-0002-0365-4478
Gwaltney, Chad
Pieske, Burkert
-
Funding
Funding for this research was provided by:
Bayer Yakuhin, Ltd.
- License Information
-
More Information
Article History
Received: 10 December 2019
Accepted: 8 July 2020
First Online: 17 July 2020
Ethics approval and consent to participate
: This study was approved by the ethics committee of the NPO Clinical Research Promotion Network Japan. This was a retrospective, observational study with the secondary use of trial data, and thus it involved no patient recruitment.
: Not applicable.
: EF is an employee of Bayer Yakuhin, Ltd. HO has received advisory fee from Bayer Yakuhin, Ltd. LB and LR are employees of Bayer AG. TT and YH are employees of Clinical Study Support, Inc. CG has received consulting fees from Bayer AG, Bayer HealthCare Pharmaceuticals, and Bayer Yakuhin, Ltd. BP has received research funds from Bayer Healthcare, Servier, and Astra-Zeneca, as well as speakers honoraria/committee membership fees from Novartis, Bayer Healthcare, Daiichi-Sankyo, MSD, Stealth Peptides, Astra-Zeneca, Sanofi, Vifor, and Servier.
